Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05043714
Title Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours (NEBULA)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PsiOxus Therapeutics Ltd
Indications

lung non-small cell carcinoma

endometrial carcinoma

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

carcinoma

esophageal carcinoma

hepatocellular carcinoma

stomach carcinoma

transitional cell carcinoma

skin squamous cell carcinoma

Therapies

NG-641 + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.